Folks suffering from Long COVID have been overlooked for too long.   Collecting robust data will help us understand this illness & target resources to those most impacted.   Rep. Don Beyer & I want CDC to publicly report this data because that which gets measured gets done.

Excited to share our paper exploring reduced ejection fraction in stroke patients. Sincere appreciation to all of our wonderful collaborators for this multi-center analysis: ahajournals.org/doi/abs/10.116…

Nice to see our article published demonstrating an association between the area deprivation index of communities in our catchment area and the time to hospital presentation adjusted for geospatial distance. Rachel Forman Kevin Sheth LaurenHSansing Yale Neurology

Our #LongCovid paper on 'Characterisation of internal tremors and vibration symptoms' is now published BMJ_Open; giving voice to what people are experiencing. Great team effort. Yale School of Medicine Yale Center for Infection and Immunity bmjopen.bmj.com/content/13/12/…

Excited to share our work demonstrating a link between MRI-based markers of vascular brain injury and impaired mobility in two population-based cohorts: neurologyopen.bmj.com/content/6/1/e0…

We can improve brain health outcomes in cardiac surgery if we provide life changing stroke treatments in patients who are at high risk! #BrainHealth Yale School of Medicine Charles Matouk Richa Sharma, MD, MPH Shadi Yaghi Hooman Kamel jamanetwork.com/journals/jaman…

Check out the article, "Ischemic Stroke and Reduced Left Ventricular Ejection Fraction: A Multidisciplinary Approach to Optimize Brain and Cardiac Health," ⬇️. ahajournals.org/doi/10.1161/ST… @richasharmamd Harlan Krumholz James V. Freeman @YaleHFdoc #AHAJournals

Thrilled to share our article about our machine learning algorithm that classifies ischemic stroke etiology using electronic health records. Deeply indebted to mentors + collaborators Dr. Lee Schwamm Harlan Krumholz Hooman Kamel LaurenHSansing Kevin Sheth Krishnaswamy Lab Hongyu Zhao

We are happy to share our findings about the risk of sICH among ischemic stroke patients taking pre-stroke antiplatelets. Dr. Lee Schwamm Gregg Fonarow MD Guido J. Falcone MD, ScD, MPH Ameer E. Hassan

Happy to share our article about timing of AC resumption after ICH in patients with mechanical valves. Rachel Forman Saef Izzy Megan Barra, PharmD Alex Merkler Edip Gurol ahajournals.org/doi/10.1161/JA…

Left Ventricular Injury Detected by Cardiac MRI and Incident Ischemic Stroke and Dementia Risk: The Multi-Ethnic Study of Atherosclerosis hubs.la/Q03kXJG30 #NeuroX

Happy to share our review article about acute stroke therapeutics! doi.org/10.1136/bmj-20…

In this real world study of ESUS patients with AIS, anticoagulation was found to be associated with a reduction in recurrent stroke, as opposed to anti-platelet therapy, among those with left ventricular wall motion abnormalities neurology.org/doi/10.1212/WN…

Lower risk of recurrent stroke among patients with ESUS and left ventricular dysfunction randomized to apixaban in the ARCADIA trial in our post-hoc analysis. ahajournals.org/doi/10.1161/ST… Hooman Kamel Mitchell Elkind Dinesh Jillella, MD Stroke AHA/ASA Shadi Yaghi

🌟 #ARCADIA trial post hoc analysis found that LV systolic dysfunction was linked to higher recurrent ischemic stroke risk. Apixaban — but not aspirin — reduced this risk in patients with LV dysfunction. Mitchell Elkind Hooman Kamel Shadi Yaghi

Thank you, Negar Asdaghi, for discussing our secondary analysis of ARCADIA and the heterogeneity of treatment effect we found for apixaban among patients with LV dysfunction in your wonderful podcast. Stroke AHA/ASA ahajournals.org/do/10.1161/pod…